Farallon Capital Management LLC Enanta Pharmaceuticals Inc Transaction History
Farallon Capital Management LLC
- $19.9 Billion
- Q3 2024
A detailed history of Farallon Capital Management LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Farallon Capital Management LLC holds 2,108,262 shares of ENTA stock, worth $13.4 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,108,262
Previous 2,095,000
0.63%
Holding current value
$13.4 Million
Previous $27.2 Million
19.54%
% of portfolio
0.11%
Previous 0.13%
Shares
19 transactions
Others Institutions Holding ENTA
# of Institutions
110Shares Held
21.1MCall Options Held
4.8KPut Options Held
4.6K-
Vanguard Group Inc Valley Forge, PA1.98MShares$12.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$11.8 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$9.54 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$7.03 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1MShares$6.37 Million0.17% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $132M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...